The Europe Bioprocess Bags Market would witness market growth of 15.7% CAGR during the forecast period (2023-2029).
A number of factors, including the rising demand for biopharmaceuticals like monoclonal antibodies and vaccines, improvements in bioprocess technology like single-use systems and disposable bioprocess bags, and the rising popularity of modular manufacturing, are propelling the market. Additionally, the growing need for individualized treatment encourages the creation of novel biologics and other complex medicines. These products need unique production procedures, which bioprocess bags can help with.
Bioprocess bags are needed to manufacture, store, and transport biologics to develop vaccines and protein therapies. Additionally, the pandemic has caused attention to turn toward single-use bioprocess bags. These are chosen over conventional stainless-steel tanks because they are less prone to contamination, offer more flexibility, are more affordable, and are simpler to operate.
These flexible plastic bags are engineered to resist the demanding conditions of the biopharmaceutical manufacturing process. Depending on the particular needs of the producers, they come in various sizes. The increased demand for biopharmaceuticals is predicted to drive significant market expansion. Several variables, such as an aging population, the incidence of chronic diseases, and the rising desire for individualized therapy, contribute to the increase in demand for biopharmaceuticals. As a result, the bioprocess bags market is anticipated to expand significantly during the next few years.
Based on R&D expenditures and patent applications, Germany is one of the top nations for clinical trials globally, as well as the pharmaceutical innovation center of Europe. Utilizing these competencies, numerous German organizations have played a significant role in the struggle against COVID-19. Thus, the high R&D investments and a robust biopharma and pharma industry will provide growth opportunities for the bioprocess bags due to their utilization in the industry during storing, research, etc., boosting the market expansion in the region.
The Germany market dominated the Europe Bioprocess Bags Market by Country in 2022, thereby, achieving a market value of $508.4 million by 2029. The UK market is showcasing a CAGR of 14.8% during (2023 - 2029). Additionally, The France market would register a CAGR of 16.6% during (2023 - 2029).
Based on Workflow, the market is segmented into Upstream Process, Downstream Process and Process Development. Based on Type, the market is segmented into 2D, 3D and Others. Based on End-User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, CMOs & CROs and Academic & Research Institutes. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Bioprocess Bags Market is Projected to reach USD 7.8 Billion by 2029, at a CAGR of 16.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Sartorius AG, Danaher Corporation, Saint-Gobain Group, Corning Incorporated, Meissner Filtration Products, Inc., Merck KGaA, Entegris, Inc., PROAnalytics, LLC, and CellBios Healthcare and Lifesciences Pvt Ltd.
By Workflow
By Type
By End-User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
